High-grade serous carcinoma has a poor prognosis, owing primarily to its early dissemination throughout the abdominal cavity. Genomic and proteomic approaches have provided snapshots of the proteogenomics of ovarian cancer 1, 2 , but a systematic examination of both the tumour and stromal compartments is critical in understanding ovarian cancer metastasis. Here we develop a labelfree proteomic workflow to analyse as few as 5,000 formalin-fixed, paraffin-embedded cells microdissected from each compartment. The tumour proteome was stable during progression from in situ lesions to metastatic disease; however, the metastasis-associated stroma was characterized by a highly conserved proteomic signature, prominently including the methyltransferase nicotinamide N-methyltransferase (NNMT) and several of the proteins that it regulates. Stromal NNMT expression was necessary and sufficient for functional aspects of the cancer-associated fibroblast (CAF) phenotype, including the expression of CAF markers and the secretion of cytokines and oncogenic extracellular matrix. Stromal NNMT expression supported ovarian cancer migration, proliferation and in vivo growth and metastasis. Expression of NNMT in CAFs led to depletion of S-adenosyl methionine and reduction in histone methylation associated with widespread gene expression changes in the tumour stroma. This work supports the use of ultra-low-input proteomics to identify candidate drivers of disease phenotypes. NNMT is a central, metabolic regulator of CAF differentiation and cancer progression in the stroma that may be therapeutically targeted.
, we set out to evaluate the proteome of both compartments in a systematic method. We combined developments in ultra-highsensitivity mass-spectrometry-based proteomics 9, 10 with microdissection technology to obtain an integrated picture of cancer progression.
To elucidate the proteomic changes that underlie ovarian cancer progression in both the tumour and stroma, we identified a cohort of 11 patients with HGSC with tissue from serous tubal in situ carcinoma (STIC), invasive fallopian tube lesions, invasive ovarian lesions and omental metastases (Fig. 1a, Supplementary Table 1 ). All tissues were collected prospectively during the initial debulking surgery and all patients were chemotherapy-naive. For each patient and every anatomic site, both tumour and stromal compartments were microdissected and proteins extracted using an optimized high-sensitivity, label-free proteomic workflow for low-input samples (Methods). In total, we quantified 6,944 unique protein groups from 107 analysed samples, both tumour and benign, at a protein and peptide falsediscovery rate (FDR) of less than 1%. A median of 4,942 and 4,428 proteins were quantified per tumour or stromal sample, respectively, at similar dynamic ranges and with excellent reproducibility (Pearson r = 0.98; Table 2) . Unsupervised hierarchical clustering robustly segregated tumour and stromal proteomes (Extended Data Fig. 1c ). Tumour compartments were enriched for known markers of HGSC (PAX8, MSLN, MUC16 (CA-125), EPCAM) and DNA replication and repair pathways, whereas stromal compartments were characterized by expression of extracellular matrix components and pathways that included activated fibroblast markers (for example, collagens, vimentin, versican, tenascins and myosins) ( Pairwise proteomic comparison of primary (invasive fallopian tube and ovarian lesions) and metastatic tumour compartments revealed only one protein, FABP4-previously reported to be upregulated in omental metastases and expressed at the tumour-stromal interfaceas significantly higher in omental tumour metastases 11 . By contrast, stromal proteomes clearly clustered by anatomic site, which reveals a conserved stromal response to metastasis that is shared between patients (Extended Data Fig. 2b-e) . Differential expression analysis between the stromal compartments at the four anatomic sites (STIC, fallopian tube, ovary and omentum) identified 128 differentially expressed protein groups, with most contributed by the omental-metastasisassociated stroma (FDR < 0.05, Extended Data Fig. 2d ). Among these, we identified a set of 62 protein groups that were universally up-or downregulated in all omental metastases compared to all primary (invasive fallopian tube or ovarian lesion) stromal sites (FDR < 0.01, Fig. 1d, Extended Data Fig. 2f ).
The stromal signature consisted of 21 up-and 41 downregulated proteins, which included proteins known to have tumour-supporting roles in the stroma such as FAP, LOX, TNC and VCAN and had considerable overlap with The Cancer Genome Atlas (TCGA) mesenchymal subtype (Fig. 1e, Extended Data Fig. 2g , Supplementary Table 5) . Downregulated proteins included negative regulators of TGF-β signalling such as LTBP4 and SDPR. Other proteins, such as ENPP1 and COPZ2, had no previously described roles in the tumour stroma Letter reSeArCH or the biology of CAFs. Owing to its biochemical activity and roles in epigenetic regulation 12 , upregulation of NNMT in the omental stroma was an interesting target. NNMT transfers a reactive methyl group from S-adenosyl methionine (SAM) to nicotinamide to generate S-adenosyl homocysteine (SAH) and the metabolically inert product 1-methyl nicotinamide . SAM is the universal methyl donor for histones, non-histone proteins, DNA, RNA, lipids and other metabolites. This activity generates a methyl sink in the form of 1-MNA, which leads to depletion of SAM and reduces the global methylation potential of the cell 13, 14 . NNMT-mediated SAM depletion regulates gene expression by attenuating histone methylation in cancer cells, adipocytes and embryonic stem cells [14] [15] [16] [17] (Fig. 2a) . The proteomic analysis revealed that NNMT expression was increased in the stroma of peritoneal and omental metastases compared to the benign omental, fallopian tube and ovarian stroma, including early micrometastases, which was also confirmed in a tissue microarray containing both primary and metastatic ovarian cancer samples (Fig. 2b , c, Extended Data Fig. 3a-d) . Tumour expression of NNMT did not vary significantly by anatomic site (Extended Data Fig. 3e ). In both syngeneic and autochthonous 18 mouse models of HGSC, NNMT was highly expressed in the stroma of metastases (Extended Data Fig. 3f ). High stromal NNMT was also observed in breast and colon cancer stroma, which suggests that NNMT expression is a feature of CAFs in multiple cancer types (Extended Data  Fig. 3g ).
CAFs are differentiated from normal fibroblasts by production of oncogenic extracellular matrix components, cytokine secretion, cytoskeletal rearrangements associated with smooth muscle actin (SMA) expression, increased ability to contract collagenous matrices and expression of CAF markers 8 . Knockdown of NNMT in CAFs led to a reversion of cell morphology to one that more-closely resembled normal omental fibroblasts (Fig. 2d, Extended Data Fig. 4a-c) . Knockdown or overexpression of NNMT led to a significant perturbation of its enzymatic activity, as assessed by 1-MNA production using mass spectrometry (Fig. 2e) . CAF markers, including SMA and fibronectin, were decreased upon NNMT knockdown and increased with overexpression (Fig. 2f, Extended Data Fig. 4d, e) .
NNMT was associated with expression of epithelial-mesenchymal transition markers, and transcriptional regulators of the epithelialmesenchymal transition and inhibition of NNMT attenuated the acquisition of CAF markers by normal stromal cells in response to TGF-β (Extended Data Fig. 4f ). NNMT was necessary and sufficient to induce collagen contractility (Fig. 2g) and globally regulated expression of thousands of genes, including pro-tumorigenic cytokines (Fig. 2h , Extended Data Fig. 4g, Supplementary Tables 6, 7) . In further support of NNMT as a central regulator of CAF gene expression, genes differentially expressed by NNMT in fibroblasts or CAFs were significantly enriched for gene signatures associated with the epithelialmesenchymal transition, TCGA mesenchymal subtype, and proteins that were highly expressed in the stroma of omental metastases compared to primary sites (Extended Data Fig. 4h-k) . Functionally, CAFs support and accelerate tumour growth, progression and metastasis 8, 19, 20 . Overexpression of NNMT in normal fibroblasts promoted cancer cell proliferation; conversely, knockdown of NNMT in CAFs attenuated cancer cell proliferation and chemotaxis (Fig. 2i, j, Extended Data  Fig. 4l, m) . CILP  CNN2  COL11A1  COMP  COPZ2  CTHRC1  ENPP1  FABP4  FBLN2  ITGB5  LEPREL2  LOX  MXRA5  NNMT  NPNT  OMD  SDC1  SFRP4  THBS2  TNC  VCAN  CILP  CNN2  COL11A1  COMP  COPZ2  CTHRC1  ENPP1  FABP4  FBLN2  ITGB5  LEPREL2  LOX  MXRA5  NNMT  NPNT  OMD  SDC1  SFRP4  THBS2  TNC  VCAN  CILP  CNN2  COL11A1  COMP  COPZ2  CTHRC1  ENPP1  FABP4  FBLN2  ITGB5  LEPREL2  LOX  MXRA5  NNMT  NPNT  OMD  SDC1  SFRP4  THBS2  TNC  VCAN  CILP  CNN2  COL11A1  COMP  COPZ2  CTHRC1  ENPP1  FABP4  FBLN2  ITGB5  LEPREL2  LOX  MXRA5  NNMT  NPNT  OMD  SDC1  SFRP4  THBS2  TNC Significantly differentially expressed proteins are highlighted in green (tumour) or purple (stroma). Two-sided t-test FDR < 0.01, n = 11 patients. e, Heat map of proteins upregulated in omental stromal signature of metastasis across all patients (rows) and anatomic sites (STIC, fallopian tube, ovary and omentum). Undetected values are black; missing samples are white. The box plots in b define the range of the data (whiskers), 25th and 75th percentiles (box), and medians (solid line).
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We hypothesized that high stromal NNMT expression drives gene expression changes and acquisition of the CAF phenotype through hypomethylation of DNA, RNA or histones through attenuation of the SAM:SAH ratio (that is, methylation potential of the cell) 14 . Indeed, methylation potential was directly regulated by NNMT expression, as assessed by metabolite profiling with mass spectrometry. NNMT knockdown increased the SAM:SAH ratio, whereas NNMT overexpression led to a decrease (Fig. 3a) . Nicotinamide levels were negatively associated with NNMT expression (Fig. 3a) . Knockdown of NNMT led to increased levels of NAD + (H) and was associated with increased expression of NAD-dependent sirtuin target genes such as catalase and CD36, and decreased acetylation of H3K9 and α-tubulin 15, 21 (Extended Data Fig. 5 ). Targeted metabolomics identified conserved metabolic changes upon both knockdown and overexpression of NNMT (Extended Data Fig. 6a, Supplementary Table 8 ). In particular, NNMT regulated the polyamine pathway and increased levels of 5-methylthioadenosine, an inhibitor of SAH hydrolase that contributes to global hypomethylation 22 (Extended Data Fig. 6b-d) . NNMT expression induced genome-wide DNA-methylation changes that significantly altered methylation status in the promoter regions of genes, and was enriched for genes involved in collagen production and myosin-driven contractility (Fig. 3b, Extended Data Fig. 7a, b,  Supplementary Tables 9, 10 ). Inhibition of DNA methylation with 5-azacytidine increased expression of CAF markers and collagen contractility, which supports a direct role for DNA hypomethylation in regulating the CAF phenotype (Extended Data Fig. 7c, d ).
To understand how NNMT affects histone methylation, we performed targeted histone proteomic analyses, using a multi-reaction monitoring approach to quantify relative levels of histone lysine and arginine methylation 23 . NNMT knockdown increased histone methylation at residues associated with transcriptional regulation, including an increase in H3K4 and H3K27 trimethylation (me3; Fig. 3c ). Immunoblotting confirmed that H3K27 and H3K4 trimethylation was perturbed upon knockdown or overexpression of NNMT (Fig. 3d) . Histone methylation was metabolically sensitive to cellular methylation potential and extracellular methionine concentration (Extended Data Fig. 7e, f) . Genes regulated by NNMT overexpression were associated with gene sets regulated by H3K27 demethylation (Extended Data Fig. 8a ). Chromatin immunoprecipitation sequencing (ChIP-seq) of cells that overexpress NNMT found that NNMT activity reduced global H3K27 occupancy, including at the promoters of NNMT-regulated genes (Fig. 3e, f, Extended Data Fig. 8b , c, Supplementary Table 11 ). These data suggest that NNMT mediates genome-wide epigenetic and transcriptional changes through hypomethylation of repressive chromatin marks (Extended Data Fig. 8d ). Cartilage oligomeric matrix protein (COMP)-an extracellular matrix protein 24 , which was the most upregulated protein in all metastatic stroma samples (Fig. 1d) -is highly expressed in the stroma of omental NNMT is not expressed in the stroma of normal fallopian tube, ovary or omentum. Scale bars, 100 μm (25 μm for omental metastases 4×). c, Stromal NNMT expression is increased in omental and peritoneal metastases compared to ovarian sites (chi-squared test). d, Knockdown of NNMT in CAFs leads to a more elongated morphology resembling normal omental fibroblasts (GFP). Scale bar, 10 μm. e, Production of 1-MNA is attenuated upon knockdown and enhanced upon overexpression of NNMT. Two-sided t-test, n = 3 biological replicates. f, Immunoblot of CAF markers (fibronectin, Fn1; SMA) upon knockdown or overexpression of NNMT. g, Effect of NNMT overexpression or knockdown on collagen contractility. Two-sided t-test, n = 3 biological replicates. h, Gene expression analysis identified thousands of genes that were significantly differentially expressed (red or blue) upon knockdown (left) or overexpression (right) of NNMT. FDR ANOVA < 0.01, n = 3 biological replicates. i, Proliferation (doubling time) of HeyA8 and TYK-nu ovarian cancer cells following treatment with the indicated conditioned medium. Proliferation rate increases (doubling time decreases) with NNMT overexpression and decreases (doubling time increases) upon knockdown. Two-sided t-test, n = 3 biological replicates. j, Quantification of chemotaxis in response to conditioned medium from CAFs expressing shCtrl or shNNMT constructs. Two-sided t-test, n = 3 biological replicates. All bar graphs represent mean of data and error bars are s.e.m.
Letter reSeArCH metastases, and its transcription is tightly regulated by NNMT expression (Extended Data Fig. 8e-g ). Histone methylation at the COMP promoter was increased upon knockdown of NNMT, which supports a central role for NNMT in functionally regulating histone methylation of genes that are differentially expressed (Extended Data Fig. 8g ). Treatment of CAFs that express short-hairpin RNA (shRNA) targeting NNMT (shNNMT) with the EZH2 histone methyltransferase inhibitor DZNep, the general histone methyltransferase inhibitor 3DZA or knockdown of EZH2 restored expression of CAF markers and promoted collagen contractility 8 ( Fig. 3g , h, Extended Data Fig. 9 ). In a syngeneic model of HGSC metastasis, cancer cell metastasis to the omentum was significantly increased when ID8 cells were pretreated with conditioned medium from fibroblasts overexpressing NNMT (Fig. 4a) . The co-injection of HGSC cells with CAFs expressing control shRNA (shCtrl) or shNNMT constructs found that knockdown of stromal NNMT also reduced in vivo proliferation and overall tumour burden (Fig. 4b, Extended Data Fig. 10a ). Recently, a small molecule inhibitor of NNMT was used to treat high-fat-diet-induced obesity in mouse models 21 . The inhibitor, 5-amino-1-methylquinolin-1-ium (NNMTi), was effective at inhibiting NNMT at micromolar concentrations and demonstrated target engagement as assessed by the cellular thermal shift assay (Extended Data Fig. 10b-d) . Treatment of human CAFs with the NNMTi increased histone methylation, decreased tubulin acetylation and was specific to cells expressing NNMT (Fig. 4c , Extended Data Fig. 10e, f) . NNMT inhibition did not affect the viability of CAFs or ovarian cancer cells (Extended Data Fig. 10g-i) . In vivo treatment with the NNMTi decreased tumour burden in an orthotopic intraperitoneal model of ovarian cancer metastasis (Fig. 4d ), reduced tumour cell proliferation and increased stromal H3K27 trimethylation (Extended Data Fig. 10j-m) .
Although NNMT was primarily expressed in the stroma of omental metastases, a subset of patients had high stromal expression of NNMT in primary sites (Figs. 1e, 2c ). The tissue microarray used to validate stromal NNMT expression was also used to evaluate the prognostic role of NNMT in chemotherapy-naive HGSC 25 . We found that high stromal NNMT protein expression in primary sites was associated with a significantly worse recurrence-free and overall survival and platinum resistance (median survival of 349 versus 598 days and 737 versus 1,489 days, respectively; Supplementary Table 12 Using laser-capture microdissection combined with an optimized high-sensitivity proteomic pipeline, we quantified up to 5,000 unique protein groups per sample from as little as 5,000 cancer cells. This approach enabled compartment-resolved proteomic analysis of both tumour and stromal compartments across the HGSC progression series from STIC to metastatic tumours and revealed a metastatic stromal signature. Our results emphasize the molecular heterogeneity of ovarian cancer, and reveal that tumour proteomes within individual patients are relatively stable during progression-as was also recently observed in breast cancer 26 . The absence of a proteomic signature that differentiates STIC from advanced cancers suggests that STIC likewise already possesses the molecular aberrations at both the genomic and proteomic levels associated with a fully developed cancer, as suggested by recent genomic studies 27, 28 . Despite the marked genetic and proteomic heterogeneity of epithelial ovarian cancer across patients, the metastatic stromal proteome was notably uniform and characterized by high NNMT expression and NNMT-regulated gene and protein expression. NNMT metabolically reprograms the epigenome of the stroma to co-opt NNMT-dependent processes that occur during stem cell priming 17 , metabolic syndrome 15 and tumour aggressiveness 14 ( Fig. 4f) . Whereas CAF gene expression can be regulated by chromatin Letter reSeArCH modifiers and DNA methylation 29, 30 , we find that metabolically defined histone methylation has a central role in defining the pro-tumorigenic role of the stroma. Inhibition of NNMT activity led to a reversion of the CAF phenotype, which suggests that stromal methyltransferase activities can be targeted to normalize the metastatic stroma and should be further explored as treatment targets for cancer.
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Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/s41586-019-1173-8. Table 1 ). All human tissue samples were collected with informed consent and in compliance with University of Chicago Institutional Review Board-approved protocols (13372 and 13248) and in accordance with the Declaration of Helsinki. Laser-capture microdissection. Samples were prepared as previously described 27 . Formalin-fixed, paraffin-embedded (FFPE) specimens were sectioned with a microtome (10-μm sections) and mounted on Leica PEN-membrane Membrane Slides (2 μm). Slides were deparaffinized with xylene and rehydrated through graded alcohols and water. Sections were stained with Mayer's haematoxylin (Sigma) and dehydrated through graded alcohols and xylene. Tumour and stromal tissues were dissected with a Leica LMD 6500 laser microdissection system and tumour and stromal samples collected in 0.5-ml tubes. Depending on the FFPE specimen, an area of 1-5 × 10 6 μm 2 was collected (approximately 5-25,000 cells, as derived from dissected area × slide thickness / average mammalian cell volume of 2,000 μm 3 , BNID 100434). FFPE tissue preparation for mass spectrometry analysis. FFPE tissue lysis was adapted and optimized from previously described workflows 31, 32 . Microdissected tissue was collected in 50 μl of lysis buffer (50% 2,2,2-trifluoroethanol (TFE) and 5 mM dithiothreitol in 25 mM NH 4 HCO 3 buffer) and centrifuged for 5 min at maximum speed to collect all remaining tissue. Samples were boiled at 90 °C for 60 min and briefly centrifuged every 10 min to avoid drying out during lysis. Subsequently, samples were sonicated for 10 min (level 5, Bioruptor Plus, Diagenode). After centrifugation for 10 min at maximum speed, supernatants were transferred to new tubes and alkylated with 20 mM iodoacetamide for 30 min in the dark. Samples were vacuum-concentrated for 30 min at 45 °C (until approximately 10 μl buffer remained). Forty microlitres of fresh digestion buffer (10% TFE and trypsin in 50 mM NH 4 HCO 3 ) was added in a trypsin (Promega) to total protein ratio of approximately 1:50. Digestion was carried out at 37 °C overnight and digestion stopped by addition of 1% TFA. Samples were vacuum-evaporated to a volume of 5-10 μl and resuspended in 100 μl 0.2% TFA and 2% acetonitrile before desalting with C18 StageTips. Samples were stored at −20 °C until MS analysis. Liquid chromatography (LC)-mass spectrometry (MS) analysis. Quadrupole Orbitrap mass spectrometers 33, 34 (Q Exactive and Q Exactive HF, Thermo Fisher Scientific) coupled to an EASY-nLC 1000 HPLC system (Thermo Fisher Scientific) via a nano-electrospray source were operated in data-dependent mode for LC-MS analysis of peptides. LC columns (75-μm inner diameter, 50-cm length) were packed in-house with C18 particles (1.9 μm, Dr. Maisch GmbH, Germany). Peptides were separated with a 250 min HPLC gradient from 2% to 60% in buffer B (80% acetonitrile, 0.5% formic acid) at a flow-rate of 200 nl min −1
. We used a resolution of 70,000 at m/z 200 (60,000 for Q Exactive HF) for survey scans. The scan range was set to 300 to 1,650 m/z. Up to the three most-abundant MS1 features (charge ≥ 2) were selected for high-energy collisional dissociation fragmentation at a resolution of 17,500 at m/z 200 (15,000 for Q Exactive HF). Dynamic exclusion of sequenced peptides was set to 45 s. Ion injection times and ion target values were set to 20 ms and 3 × 10 6 for the survey scans and 220 ms and 1 × 10 5 for the MS/MS scans, respectively. Data were acquired using Xcalibur software (Thermo Scientific). Data analysis of proteomic raw files. MS raw files were processed with MaxQuant 35 (version 1.5.3.15). The Andromeda search engine 36 of MaxQuant was used for peptide and protein identification. Andromeda is a probability-based search engine that employs a target-decoy approach to identify peptides and proteins at an FDR of less than 1%. The UniProtKB database release (August 2015) was used as the forward database. MaxQuant automatically generated a reverse decoy database based on the provided forward database. Proteins that could not be distinguished based on the identified peptides were grouped into protein groups 35 . The MaxLFQ 37 algorithm was used for label-free proteome quantification. MaxLFQ is a peptide intensity-based algorithm that makes use of high-resolution 3D peptide features in mass-to-charge, retention time and intensity space.
For each protein, peptide ratios were calculated in a pairwise manner and combined with protein ratios by calculating the median of all peptide ratios. Only the exact same peptide species was considered for each pairwise calculation. A leastsquares analysis was then used to reconstruct the relative protein abundance across samples, which preserves the total summed intensity for a protein over all samples. A minimum of one ratio count for each pairwise comparison was required and the final list of protein quantifications was filtered for proteins with a minimum of two razor and unique peptides for each protein. The 'Match Between Runs' feature of MaxQuant was enabled to match high-resolution MS1 features between runs. All statistical and bioinformatics analyses were done using Perseus 38 (MaxQuant environment) or the R framework. For pairwise proteomic comparisons, we used a two-sided t-test statistic including a permutation-based FDR of 1% and an s0 value 39 of 2. Missing values were imputed based on a normal distribution (width, 0.15; downshift, 1.8).
Tissue immunohistochemistry and immunofluorescence. FFPE tissue specimens were cut at 10 μm, deparaffinized in xylene, and rehydrated through graded ethanol solutions. Following heat-mediated, sodium citrate antigen retrieval (10 mM sodium citrate, 0.05% Tween 20, pH 6), slides were stained with anti-NNMT (Santa Cruz G-4; 1:200) or anti-COMP (Thermo Fisher Scientific MA1-20221; 1:100) antibodies and processed with the VECTASTAIN Elite ABC HRP kit and DAB Substrate Kit (Vector Laboratories). Slides were counterstained with haematoxylin and dehydrated through graded alcohols and xylene. For immunofluorescence, slides were stained with fluorescently-labelled secondary antibodies (1:200; Thermo Fisher) and Hoechst 33258 (1:200; Molecular Probes). Confocal microscopy was performed with a Zeiss LSM510 and images processed with Image J 1.50j. Tissue microarray analysis. Assembly and construction of the ovarian cancer tissue microarray have been previously described 40 . NNMT immunohistochemical reactivity was scored without knowledge of clinical outcome by two experienced pathologists (S.M. and R.L.). Each sample was scored based on the percentage of positive cells in each compartment (0, no staining; 1, <30%; 2, 30-50%; 3, ≥50%); staining intensity was similar across all samples. Expression was considered 'low' if the staining intensity was 0 or 1 and 'high' if 2 or 3. Analysis was limited to the ovarian compartment of chemotherapy-naive patients (upfront debulking) with high grade serous pathology (n = 96 patients; Supplementary Table 12 ). Kaplan-Meier survival curves and statistical analyses of overall and progression-free survival were performed with GraphPad Prism 7 using the Mantel-Cox (log-rank) test. Isolation of primary cells. CAFs were isolated from tumour-containing omental tissue of patients with HGSC. Normal omental fibroblasts (NOFs) were isolated from omental tissue from female patients undergoing surgery for benign conditions. CAFs and NOFs were isolated and confirmed as previously described 41 . Tissues were thoroughly rinsed with PBS before mincing and digestion (12-18 h) with collagenase (3 mg ml . All cells were cultured at 37 °C in a humidified incubator at 5% CO 2 . For experiments, CAFs and fibroblasts (3T3 and 293T cells) were grown in 10 μM methionine medium supplemented with dialysed 10% FBS. For some experiments, cells were treated with 1 μM DZNep or 1 μM 3DZA or vehicle (DMSO) control for 72 h. All cells lines were regularly tested and found to be negative for mycoplasma and were authenticated (IDEXX Bioresearch short tandem repeat marker profiling). Plasmids and expression. shRNA oligonucleotides were designed using the shRNA Designer from BiOSETTIA (using accession number NM_006169) and cloned into the pLV-hU6-CMV-Green backbone using the manufacturer's protocol (Supplementary Table 14) . CAFs were infected with non-targeting shCtrl (5′-GCAGTTATCTGGAAGATCAGG-3′) or shNNMT (5′-GCTACA CAATCGAATGGTT-3′) constructs; 3T3 normal fibroblasts were infected with pLenti6 empty vector control or pLX304-NNMT overexpression vector (HsCD00442343; DNASU). CAFs were immortalized with pBABE-neo-hTERT (1774; Addgene). To produce lentivirus, 293T cells were seeded at 1 × 10 6 cells per 6-cm dish in DMEM supplemented with 10% FBS. After 18 h, cells were transfected with 1 μg expression vector, 0.9 μg pCMV-dR8.2 packaging vector (8455; Addgene), and 0.1 μg pCMV-VSV-G expression vector (8454; Addgene) using Lipofectamine 2000. Viral supernatant was collected at 48 and 72 h post-transfection, filtered through a 0.8-μm filter and added to recipient cells with 4 μg ml −1 polybrene for 8-12 h before selection with puromycin (2 μg ml −1 ) or blasticidin (1 μg ml −1 ). For transient transfections, cells were seeded in a 6-well dish and transfected with 5 nmoles small interfering (si)RNA pools (GE Dharmacon) using Lipofectamine 2000 (Thermo Fisher) in OptiMEM reduced serum medium (Thermo Fisher). Each pool contained four siRNA sequences for NNMT (5′-GAAAGAGGCUGGCUACACA-3′, 5′-GAGGUGAUCUCGCAAAGUU-3′, 5′-GAAGGGAGACCUGCUGAUU-3′ and 5′-GCUCCUCUCUGCUUGUGAA-3′), EZH2 (5′-CAAAGAAUCUAG CAUCAUA-3′, 5′-GAGGACGGCUUCCCAAUAA-3′, 5′-GCUGAAGCCUCAA UGUUUA-3′ and 5′-GAAUGGAAACAGCGAAGGA) or non-targeting controls (5′-UAGCGACUAAACACAUCAA-3′, 5′-UAAGGCUAUGAAGAGAUAC-3′, , followed by an isocratic gradient of 100% B for 10 min at 0.4 ml/min. Then, the column was equilibrated with 0% B for 5 min at 0.4 ml min Table 13 ). After washing with TBST, the membrane was incubated with secondary antibodies (Thermo Fisher Scientific) conjugated to horseradish peroxidase at 1:5,000 dilution in 5% NFDM/TBST for 1 h at room temperature. Proteins were visualized using Clarity Western ECL Substrate (Bio-Rad) or SuperSignal West Femto Substrate (Fisher Scientific). For the cytokine array, cells were seeded at 3 × 10 6 cells per 15 cm plate and grown for 72 h in growth medium. Conditioned medium was collected, filtered through a 0.22-μm filter, and processed with the Proteome Profiler Human Cytokine Array Kit, Panel A (R&D Systems) following the manufacturer's recommendations. Images were quantified using ImageJ. Full-length immunoblots are available in Supplementary Data. Quantitative PCR with reverse transcription (RT-qPCR). Total RNA was isolated and treated with DNase using RNeasy Mini Kit (Qiagen) according to the manufacturer's protocol. Reverse transcription of 2 μg total RNA was carried out using the High Capacity cDNA Reverse Transcription Kit (ThermoFisher Scientific). qPCR was performed with TaqMan probes and TaqMan Fast Advanced Master Mix or custom primers (IDT) and Fast SYBR Green Master Mix on an Applied Biosystems StepOnePlus Real-Time PCR System and analysed using the 2 -ΔΔCt method (Supplementary Table 14) . Collagen contractility assay. Indicated cells were trypsinized and diluted to 2 × 10 5 cells/ml in growth medium. Four hundred microlitres of diluted cells were mixed with 200 μl of rat tail collagen (5 mg ml
; BD Biosciences) and neutralized with 5 μl 1 N NaOH and transferred to a 24-well plate. After 20 min of incubation, collagen gel was freed from the edges with a pipette tip and 600 μl of cell culture medium added to the well. Collagen gels were incubated at 37 °C for 24 h before fixation (4% paraformaldehyde) and staining with Eosin-Y (Sigma) before imaging to quantify collagen gel area with ImageJ 1.50j. Proliferation assays. Ovarian cancer cells were seeded at 1,000 cells per well in a 96-well plate and allowed to adhere for 24 h before addition of conditioned medium (72 h) from the indicated cells. After 24 h and 48 h, nuclei were visualized by addition of Hoechst 33258 (1:5,000) and wells fluorescently imaged with a Zeiss Axiovert Observer.A1 to extract cell number and doubling time. Images were analysed with ImageJ 1.50j. Migration assays. Forty thousand cells in serum-free medium were added to the top chamber of an 8.0 μm PET cell culture insert (Falcon) with conditioned medium (72 h) from indicated cells in the bottom reservoir. After 12 (HeyA8) or 18 (TYK-nu) hours, cells were fixed with 4% PFA in PBS, representative fluorescent images collected with a Zeiss Axiovert Observer.A1, stained with 0.1% crystal violet, washed extensively with PBS and dried. Crystal violet was released with 10% acetic acid and the absorbance at 520 nm measured to quantify relative migration. Gene expression analysis. RNA was collected from CAFs expressing shCtrl or shN-NMT constructs and WI-38 normal fibroblasts in triplicate (AllPrep DNA/RNA Mini Kit, Qiagen). Total RNA (700 pg) was used to generate double-stranded cDNA, fragmented and biotin-labelled according to Affymetrix GeneChip Pico Reagent Manual (Thermo Fisher Scientific). Fragmented and labelled cDNA (5.5 μg) was hybridized to Human Clariom S arrays for 16 h at 45 °C and 60 rpm in an Affymetrix Hybridization Oven 640. Arrays were washed and stained with streptavidin phycoerythrin in an Affymetrix Fluidics Station 450. Arrays were scanned using the Affymetrix Gene Chip Scanner 3000 7G and CEL intensity files generated by GeneChip Command Console Software. Data were processed with Transcriptome Analysis Software 4.0 using Signal Space Transformation-Robust Multi-Chip Analysis (SST-RMA). All analyses were performed at the probe level. Gene set enrichment analysis (GSEA) was performed with GSEA v2.2.0. Global metabolite profiling using three mass spectrometry platforms. Five million CAFs expressing shCtrl or shNNMT constructs and 4.5 million 3T3 cells expressing control or NNMT overexpression constructs were collected in triplicate by trypsinization and flash-frozen in liquid nitrogen. Untargeted metabolomics datasets were acquired using three mass spectrometry platforms at the West Coast Metabolomics Center, University of California, Davis. Metabolites were extracted as previously described 43, 44 . For hydrophilic interaction liquid chromatography (HILIC) quadrupole time of flight (qTOF) for polar metabolites, the dried polar aliquot was resuspended in 80:20 acetonitrile:water (v/v) with internal standards. HILIC-qTOF was performed with a Agilent 1290 infinity UHPLC instrument with a Waters Acquity UPLC BEH Amide column coupled to an Agilent 6530 mass spectrometer equipped with an ion funnel (iFunnel) electro spray ionization source, as described 45 . For charged surface hybrid (CSH) qTOF for lipidomics, dried extracts were resuspended using a mixture of methanol/toluene (9:1, v/v) (60 μl) containing an internal standard (12-((cyclohexylamino)carbonyl)amino)-dodecanoic acid (CUDA)). For CSH-qTOF, an Agilent 1290 Inifinity LC systems was coupled to either an Agilent 6530 (positive ion mode) or an Agilent 6550 (negative ion mode) mass spectrometer 44, 46, 47 . GC-TOF was performed with an Agilent 6890 gas chromatography instrument with an Rtx-5Sil MS column coupled to a Leco Pegasus IV time of flight mass spectrometer as previously described 46, 48 . For GC-TOF platforms, ChromaTOF version 4.50.8 was used for data preprocessing and analysed with the BinBase algorithm as previously described 44, 49 . For CSH-qTOF and HILIC platforms, raw data files were converted to .abf using the ABF converter and MS-DIAL software was used for peak detection, alignment, gap filling and annotations. Metabolite identifications were performed on three levels according to Metabolomics Standards Initiative 50 by using chromatographyspecific databases in conjunction with mass spectral libraries (Mass Bank of North America and NIST 17), all publicly available on MoNA (http://mona.fiehnlab. ucdavis.edu/). Global DNA methylation arrays. WI-38 lung fibroblasts expressing control or NNMT overexpression constructs and CAFs expressing shCtrl or shNNMT constructs were passaged for 21 days in 10 μM methionine growth medium and DNA and RNA extracted in triplicate using the Qiagen AllPrep DNA/RNA Mini Kit per manufacturer's instructions for parallel gene expression and DNA methylation analysis. DNA methylation was assessed using Illumina Infinium MethylationEPIC beadchip arrays at the University of Chicago Center for Functional Genomics 51 . The detectionP function from minfi was used to calculate probe detection P values. The sample means were examined to ensure all samples had a mean P value of detection less than 0.01. Background correction with dye-bias normalization and subsequent quantile normalization was applied using the preprocessNoob and preprocessQuantile functions from minfi. Probes were removed with too few remaining beads targeting a given site using the pfilter function from wateRmelon. Probes were removed that were crosshybridizing, were located on sex chromosomes, or where single nucleotide polymorphisms were located within two bases of the target site, using rmSNPandCH and dropLociWithSnps from the DMRcate and minfi packages, respectively. Probes that aligned to multiple locations were removed using the multi.hit data from the ChAMP package. Differential tests were carried out separately by cell type using the contrasts NNMT/Ctrl and shNMMT/ shCtrl for fibroblasts and CAFs, respectively. Tests for probe-wise differential methylation were carried out with limma using M-values. Quantitative histone methylation proteomics. Nuclei were isolated using gentle detergent treatment (0.3% NP-40 in NIB-250 buffer) of cells and centrifugation at 600g and washed with NIB-250 buffer. Histones were acid-extracted and derivatized with propionic anhydride both before and following trypsin. Propionylated histone peptides were resuspended in 50 μl water with 1% TFA, and 3 μl were injected in 3 technical replicates on nanoLC/triple quadrupole MS which consisted of a Dionex UltiMate 3000 coupled to a ThermoFisher Scientific TSQ Quantum triple quadrupole mass spectrometer. Buffer A was 100% LC-MS grade water with 0.1% formic acid and buffer B was 100% ACN. The propionylated peptides were loaded onto an in-house packed C18 trapping column (4 cm × 150 μm; Magic AQ C18, 3 μm, 200 Å Michrom) for 10 min at a flow-rate of 2.5 μl min −1 in 0.1% TFA loading buffer. The peptides were separated by a gradient from 1 to 35% buffer B from 5 to 45 min. The analytical column was a 10 cm × 75-μm PicoChip (1PCH7515-105H253-NV New Objective) consisting of the same C18 material as the trapping column. The triple quadrupole settings were as follows: collision gas pressure of 1.5 mTorr; Q1 peak width of 0.7 (full width at half maximum); cycle time of 3 s; skimmer offset of 10 V; electrospray voltage of 2.5 kV. SRM mass spectrometer transitions were developed as previously described 23 . Data were analysed using Skyline software (v.3.5; MacCoss Laboratory, University of Washington) with Savitzky-Golay smoothing of peaks. Automatic peak assignment and retention times were checked manually. H3K27me3 ChIP-seq and bioinformatics. Two days before sample collection, two million 3T3 cells expressing control or NNMT overexpression constructs were seeded in a 15 cm dish and grown in DMEM supplemented with dialysed FBS and 10 μM methionine. In parallel, RNA was collected from cells using the RNeasy Mini Kit (Qiagen) for gene expression analysis with RNA sequencing. After 48 h, cells were fixed with 1% formaldehyde for 10 min at room temperature. Formaldehyde was quenched with glycine and cells scraped in cold PBS. Nuclei were isolated and chromatin sheared used micrococcal nuclease (MNase) per manufacturer's suggestions (Cell Signaling SimpleChip Enzymatic Chromatin IP Kit 9003; 1,000 gel units MNase/immunoprecipitation for 20 min at 37 °C). Ten micrograms of sheared DNA was chromatin immunoprecipitated with H3K27me3 (Cell Signaling 9751) or isotype control antibody (Cell Signaling 2729). All experiments were performed in biological triplicates. Libraries were prepared using the NEBNext Ultra II DNA Library Prep Kit for Illumina (NEB) with 5 cycles of PCR and sequencing with an Illumina HiSeq 4000 (SR50). Input samples were pooled before library preparation. RNA-sequencing libraries were prepared using standard NEB library preparation protocols and sequenced with an Illumina HiSeq 2000 (PE150; Novogene).
ChIP-seq reads were preprocessed with Trimmomatic 0.36 to remove low quality data and adapters before aligning to GRCm38 with BWA aln 0.7.17. Alignments were filtered and PCR duplicates were marked using sambamba 0.6.5. Differential binding was performed with rgt-THOR 0.11.2 which can integrate biological replicates using a hidden Markov model based approach 52 . THOR incorporates GC-content correction, input DNA normalization and subtraction, and global ChIP-seq signal normalization. Peaks were annotated with homer 4.8.3 and filtered to only keep peaks with an adjusted P value < 0.05 and within 5 kb of a TSS. We integrated histone binding data with expression data by matching gene symbols of the filtered peaks (based on TSS) and differentially expressed genes (adjusted P value < 0.05). Peak heat maps were created by averaging the signals across the treatments and plotting different sets of genes using deepTools 3.1.0. RNA-sequencing reads were trimmed, low-quality reads removed and aligned to mm10 using STAR v2.5. 5-amino-1-methylquinolin-1-ium iodide (NNMT inhibitor) synthesis. An equimolar mixture of 5-aminoquinoline (Sigma-Aldrich) and iodomethane (Sigma-Aldrich) was heated at 90 °C for 2 h in isopropyl alcohol (0.5 M). After cooling to room temperature, precipitate was extracted with vacuum filtration, washed with a 1:1 mixture of isopropyl alcohol and ethanol, and dried to obtain a red powder (38.9% yield). For all experiments, 5-amino-1-methylquinolinium was dissolved in PBS and filtered through a 0.22-μm syringe filter. Recombinant human NNMT expression and purification. Human NNMT containing three alanine mutations (Addgene 40734) was cloned into the pET28-lic vector and used as a template for site-directed mutagenesis. A100K, A101E, and A103K present in the wild-type form of human NNMT as well as four additional His residues in N terminus His-tag were introduced. The resulting vector was transformed into chemocompetent Escherichia coli BL21 (DE3; NEB). 1 l of Terrific Broth medium (Invitrogen) was inoculated with overnight pre-cultures and grown to OD 600 0.6 at 37 °C, 220 r.p.m.; growth was continued at 17 °C overnight. Bacterial pellets were collected, resuspended in 50 mM Tris pH 8.0, 500 mM NaCl, 10% glycerol, 5 mM β-mercaptoethanol, 0.5 mM PMSF and lysed by sonication. Protein from the supernatant of centrifuged sonicate was purified by immobilized metal affinity chromatography using cobalt resin (Takara). Pooled fractions were further purified by size exclusion chromatography (SEC) on HiLoad 16/600 Superdex 75 pg, equilibrated with 50 mM Tris pH 8.0, 500 mM NaCl, 10% glycerol, 0.5 mM TCEP. Purity of protein fractions was assessed by SDS-PAGE. Selected, homogenous SEC fractions were pooled and protein concentrated to 10 mg ml −1 using 10-kDa molecular mass cutoff centrifugal filter units (Amicon). NNMT enzymatic activity assay. The Promega MTase-Glo Methyltransferase Assay kit was used to evaluate NNMT biochemical activity. Each reaction contained 0.04 ng of recombinant NNMT, 8 μM nicotinamide, and 6.7 μM SAM in 1× Reaction Buffer (20 mM Tris buffer pH 8.0, 50 mM NaCl, 1 mM EDTA, 3 mM MgCl2 0.1 mg ml −1 BSA, 1 mM DTT). Reactions were performed for 20 min at room temperature. MTase-Glo reagent and MTase-Glo Detection solution were added according to manufacturer's instructions and luminescence signal measured with a SpectraMax i3 plate reader and data analysed with GraphPad Prism version 7.04. Cellular thermal shift assay. CAOV3 cells (2 × 10 5 ) were resuspended in 100 μl of PBS containing cOmplete Mini EDTA-free protease inhibitor cocktail. Samples were incubated at temperatures ranging between 45 °C and 70 °C using a BioRad T100 Thermal Cycler to evaluate NNMT aggregation temperature. The negative control sample was incubated at room temperature. NNMT thermal stability upon inhibitor binding was evaluated by addition of NNMTi to cell suspensions and at 58 °C (aggregation temperature; T agg . Samples were centrifuged at 4,000g for 40 min at 4 °C. Supernatants containing the non-aggregated fraction of NNMT were separated by SDS-PAGE. Protein was visualized by immunoblotting using mouse NNMT monoclonal antibody (G4, Santa Cruz Biotechnology) and images analysed with GraphPad Prism version 7.04. Xenograft and syngeneic models. All animal experiments were conducted in compliance with approved University of Chicago Institutional Animal Care and Use Committee protocols (71951). Animals were not randomized and were not excluded. Sample size was based on pilot experiments and previous experience with the models. For the xenograft model, female nude mice (6-week old; Harlan) were subcutaneously injected in the left and right flanks with 100,000 HeyA8-Luciferase cells mixed with 200,000 CAFs expressing shCtrl or shNNMT constructs in 50% Matrigel (BD Biosciences) diluted with serum-free DMEM. Tumour burden was assessed 7 and 14 days after injection using a Xenogen IVIS 200. Maximum tumour size was limited to 1 cm in the longest dimension and was not exceeded. Luciferase imaging was performed via intraperitoneal injection of 100 μl d-luciferin (30 mg ml −1 in PBS; 0.22 μm sterile filtered) 10 min before imaging. Images were analysed with Living Image 4.4 software and proliferation rate (doubling time) extracted from luciferase flux at days 7 and 14. Mice were killed with isoflurane and tumours dissected to assess total tumour burden under blinded conditions. For the NNMT inhibitor experiment, 5 million HeyA8 cells were intraperitoneally injected in 20 female nude mice (6 weeks old, Harlan). Treatment with NNMT inhibitor was started 24 h after injection. NNMTi (20 mg kg −1 in PBS; 0.22 mm sterile filtered) or PBS (vehicle control) were administered via intraperitoneal injection every 24 h. Mice were killed with isofluorane after 10 days of treatment and tumours collected and weighed to assess total tumour burden under blinded conditions. For the syngeneic model, ID8-luciferase/GFP cells were pre-treated with conditioned medium (72 h) from 3T3 cells overexpressing NNMT or a control construct for 48 h. Animals were not randomized and were not excluded. Four million pre-treated ID8 cells were injected intraperitoneally in seven female C57BL/6 mice (6 weeks old; Harlan) and allowed to implant for 14 h before mice were killed and the omentums collected. Following imaging of the omentums (GFP), tissues were lysed with luciferase assay lysis buffer (Promega) and luciferase signal detected using a Lumat LB 9507 luminometer (Berthold Technologies). Analysis of tumour burden was conducted under blinded conditions. Statistics and reproducibility. Statistical analyses were carried out using Perseus, Excel, R and GraphPad Prism 7.01. Data are reported as mean ± s.e.m., unless otherwise noted in figure legends. Number and type of replicates are indicated in the legends of the corresponding figures. Experiments for which representative images are presented were reproduced with at least three biological replicates. Sample size was based on pilot experiments or previous experience with the models. P values are reported in the figures or figure legends and were calculated with unpaired Student's t-test for two groups or ANOVA with Tukey correction for experiments with more than two groups. For survival analyses, significance was assessed with log-rank (Mantel-Cox) test and hazard ratios calculated with log-rank test. P values less than 0.05 were considered significant (95% confidence interval). Reporting summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this paper.
Data availability
All data supporting the findings of this study are available within the paper, Extended Data Figs. 1-10 between patients. In respect to the compartment (tumour/stroma, blue; grey is undetected) one protein is differentially expressed in the tumour compartment (FABP4), whereas 128 proteins are differentially expressed in the stroma. e, Unsupervised hierarchical clustering of tumour (left, 1,474 significant proteins from d) and stroma (right, 128 significant proteins from d) proteins reveals patient-specific clustering in the tumour compartment (n = 43) whereas the stromal samples (n = 42) cluster by anatomic site. Note, all omental samples (red) across all patients cluster together. f, Unsupervised hierarchical clustering of only stromal proteins (n = 42) that are differentially expressed between primary sites (FT and Ov) and metastases (Om) reveal anatomic site-specific clusters, including a core signature of 21 proteins consistently upregulated in the stroma of omental metastases (box). g, Expression of the 21-protein signature in the TCGA subtypes reveals enhanced expression in mesenchymal subtype (n = 21 proteins). 
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Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested 
Software and code
Policy information about availability of computer code
Data collection
Proteomic mass spectrometry data was acquired using Xcalibur software (Thermo Scientific). Confocal microscopy images were collected with Zeiss ZEN software. Epifluorescence images were collected with Nikon NIS-Elements software. Microarray CEL intensity files were generated by GeneChip Command Console Software. Chromatin immunoprecipitation data and RNA sequencing data were collected with Illumina HCS1.5/RTA1.13 and CASAVA 1.6. Metabolomics data were acquired with MassHunter Data Acquisition (LC-MS/MS) or MassHunter ChemStation (GC-MS). Described in Methods.
Data analysis
Proteomic mass spectrometry data was processed with MaxQuant v1.5.3.15 using the Andromeda search engine; statistical and bioinformatics analyses were done using Perseus (MaxQuant environment) or the R framework (R version 4.4.2; R studio version 1. For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
